SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1849 |
Sector | Life Science |
Employees | 8,300 |
Revenue | 58.5B USD (2023) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
DEAL STATS | # |
---|---|
Overall | 43 of 44 |
Sector (Life Science) | 39 of 39 |
Type (Add-on Acquisition) | 31 of 31 |
State (Washington) | 1 of 1 |
Country (United States) | 31 of 32 |
Year (2023) | 1 of 2 |
Size (of disclosed) | 4 of 22 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-08 |
GBT
San Francisco, California, United States GBT is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities, starting with sickle cell disease (SCD). GBT is delivering on its goal to transform the treatment and care of SCD, a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta® (voxelotor), the first FDA-approved medicine that directly inhibits sickle hemoglobin (HbS) polymerization, the root cause of red blood cell sickling in SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a P-selectin inhibitor in Phase 3 development to address pain crises associated with the disease, and GBT021601 (GBT601), the company’s next generation HbS polymerization inhibitor. |
Buy | $5.4B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-04-28 |
Lucira
Emeryville, California, United States Lucira is a medical technology company that focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that provides molecular testing services. Lucira was founded in 2013 and is based in Emeryville, California. |
Buy | $36M |